£100 Million Investment Fuels New Global Cancer Research Teams

At the Cancer Grand Challenges Summit 2026, five new international research teams were announced, backed by over £100 million in funding. The initiative, led by Cancer Research UK (CRUK) and the National Cancer Institute (NCI), aims to accelerate progress in tackling some of the most complex questions in cancer research. The investment also includes support from the #BowelbabeFund for Cancer Research UK, Cancer Research Institute (CRI), Stichting Kinderen Kankervrij (KiKa), KWF Kankerbestrijding, Torrey Coast Foundation, and Yosemite.

Addressing Key Challenges in Cancer Research

The five teams will focus on distinct areas of cancer research, each addressing a critical challenge in the field:

Team ATLAS – Cancer Avoidance Challenge

This team investigates why some individuals at high risk of cancer never develop the disease. By studying natural cancer resistance, particularly protective immune mechanisms, ATLAS aims to identify new avenues for cancer prevention.

Team CAUSE – Mechanisms Driving Mutational Signatures Challenge

CAUSE will explore the connection between DNA damage and the unique mutational patterns found in tumors. Identifying the causes of these “mutational signatures” could reveal hidden drivers of cancer risk globally.

Team ILLUMINE – The Dark Proteome Challenge

ILLUMINE will delve into the “dark proteome”—proteins that challenge our current understanding of gene annotation—potentially uncovering new therapeutic targets.

Team InteroCANCEption – The Nervous System and Cancer Challenge

This team will map the interactions between tumors and the nervous system, redefining cancer as a disease embedded within the body’s physiological networks. This research could reshape our understanding of tumor progression, immunity, and symptom management.

Team REWIRE-CAN – Rewiring Cancer Cells Challenge

REWIRE-CAN will test whether cancer cells can be destabilized by pushing them beyond their signaling limits, potentially collapsing tumor survival mechanisms.

Introducing Project AURORA: An AI Co-Scientist

Alongside the new teams, Cancer Grand Challenges introduced Project AURORA, an agentic AI co-scientist led by Marinka Zitnik. AURORA is designed to assist researchers in generating hypotheses, designing experiments, and accelerating discovery across the Cancer Grand Challenges ecosystem.

A Collaborative Effort

Lorenzo de la Rica, Research Lead at Cancer Grand Challenges, highlighted the collaborative nature of the initiative, emphasizing two years of function with the international scientific community in shaping the challenges and supporting multidisciplinary teams.

“At its core, this investment is about one thing: accelerating progress for people affected by cancer,” said de la Rica. “What a great day for global cancer research! Excited for what comes next!”

Further details on the teams and their research can be found in a perspective published in Cancer Discovery and on the Cancer Grand Challenges website.